2010
DOI: 10.1016/j.bmc.2010.06.098
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0
2

Year Published

2013
2013
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 68 publications
(32 citation statements)
references
References 38 publications
0
26
0
2
Order By: Relevance
“…Fluoroquinolones were widely used in human and veterinary medicine for the treatment of infectious diseases [5][6][7]. Ciprofloxacin, a fluoroquinolone antibacterial agent [8,9], has a wide range of antibacterial activity, which is highly active against various Gram-positive and Gram-negative bacteria.…”
Section: Introductionmentioning
confidence: 99%
“…Fluoroquinolones were widely used in human and veterinary medicine for the treatment of infectious diseases [5][6][7]. Ciprofloxacin, a fluoroquinolone antibacterial agent [8,9], has a wide range of antibacterial activity, which is highly active against various Gram-positive and Gram-negative bacteria.…”
Section: Introductionmentioning
confidence: 99%
“…15 Recently, the synthesis of fluoroquinolones has become of increasing interest since the quinoline skeleton is present in many chemotherapeutic agents. [16][17][18] These findings prompted us to explore the combination of an oxazole nucleus and fluorine atom within the pyranoquinolinone moiety in one molecular framework. In continuation of our research focused on the chemistry of pyrano [3,2-c]quinolinedione derivatives, 19,20 we now disclose the preparation of a new synthetically valuable 3-aminopyranoquinolone derivative in order to obtain a novel series of pyranoquinolinones incorporating an oxazole and/or fluorophenyloxazole at face c. We hope that these new compounds will have useful biological activities.…”
Section: Introductionmentioning
confidence: 99%
“…The structure-activity relationship of the quinolones has been the subject of extensive reviews [4][5][6][7][8][9][10][11][12][13][14][15][16] . In our continuous effort to develop new chemotherapeutics with enhanced activities against resistant bacterial strains 17,18 , we introduced a new class of tricyclic compounds, namely thiadiazoloquinolones 19 . In our methodology, we took advantage of many known benzothiadiazoles ( Figure 2) with diverse biopharmaceutical activities [20][21][22][23][24][25][26] and we hybridized the thiadiazole moiety with the fluoroquinolone structure to introduce the new compound 9-cyclopropyl-4-fluoro-6-oxo-6,9-dihydro [1,2,5]thiadiazolo [3,4-h]quinoline carboxylic acid (16).…”
Section: Introductionmentioning
confidence: 99%